telaprevir

09/15/2011 - 10:01

University of Cincinnati research published in the Sept. 14, 2011, advance online edition of the New England Journal of Medicine shows that patients with hepatitis C who took a combination medication—a telaprevir-based regimen that is commonly used to treat the illness—for 24 weeks were cured.